We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A research team at the Queensland University of Technology (QUT) in Australia has discovered a new binding site on the SARS-CoV-2 spike (S) protein, which could be used as a target for anticoagulant drugs.